Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Cristina Zucchinetti"'
Autor:
Ivan Borrello, Kimberly A. Noonan, Xiaobu Ye, Anita Gandhi, Marissa Vignali, Catherine Sanders, Sarah Johnson, Rachel M. Gittelman, Christian B. Gocke, Philip Imus, Syed Abbas Ali, Cristina Zucchinetti, Lakshmi Rudraraju, M. Amanda Stevens, Amy Sidorski, Anna Ferguson, Carol Ann Huff, Luca Biavati
Supplementary Table S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6aa7e33178d4a69ae829a933f18e9de
https://doi.org/10.1158/1078-0432.22484040.v1
https://doi.org/10.1158/1078-0432.22484040.v1
Autor:
Ivan Borrello, Kimberly A. Noonan, Xiaobu Ye, Anita Gandhi, Marissa Vignali, Catherine Sanders, Sarah Johnson, Rachel M. Gittelman, Christian B. Gocke, Philip Imus, Syed Abbas Ali, Cristina Zucchinetti, Lakshmi Rudraraju, M. Amanda Stevens, Amy Sidorski, Anna Ferguson, Carol Ann Huff, Luca Biavati
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c4364585f7d463c7fa30119b17786c
https://doi.org/10.1158/1078-0432.22484046
https://doi.org/10.1158/1078-0432.22484046
Autor:
Ivan Borrello, Kimberly A. Noonan, Xiaobu Ye, Anita Gandhi, Marissa Vignali, Catherine Sanders, Sarah Johnson, Rachel M. Gittelman, Christian B. Gocke, Philip Imus, Syed Abbas Ali, Cristina Zucchinetti, Lakshmi Rudraraju, M. Amanda Stevens, Amy Sidorski, Anna Ferguson, Carol Ann Huff, Luca Biavati
Purpose:This proof-of-principle clinical trial evaluated whether an allogeneic multiple myeloma GM-CSF–secreting vaccine (MM-GVAX) in combination with lenalidomide could deepen the clinical response in patients with multiple myeloma in sustained ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fd45c6577b2a07af539ca6085c64a7
https://doi.org/10.1158/1078-0432.c.6531312.v1
https://doi.org/10.1158/1078-0432.c.6531312.v1
Autor:
Ivan Borrello, Kimberly A. Noonan, Xiaobu Ye, Anita Gandhi, Marissa Vignali, Catherine Sanders, Sarah Johnson, Rachel M. Gittelman, Christian B. Gocke, Philip Imus, Syed Abbas Ali, Cristina Zucchinetti, Lakshmi Rudraraju, M. Amanda Stevens, Amy Sidorski, Anna Ferguson, Carol Ann Huff, Luca Biavati
Supplementary Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59d4fa2ff600dd171240354d0c490f4b
https://doi.org/10.1158/1078-0432.22484043.v1
https://doi.org/10.1158/1078-0432.22484043.v1
Autor:
Cristina Zucchinetti, Christian B. Gocke, Rachel M. Gittelman, Xiaobu Ye, Syed Abbas Ali, Anna Ferguson, Anita Gandhi, Lakshmi Rudraraju, Catherine Sanders, Philip H. Imus, Kimberly A. Noonan, Ivan Borrello, Sarah K. Johnson, Amy Sidorski, M Amanda Stevens, Luca Biavati, Carol Ann Huff, Marissa Vignali
Publikováno v:
Clin Cancer Res
Purpose: This proof-of-principle clinical trial evaluated whether an allogeneic multiple myeloma GM-CSF–secreting vaccine (MM-GVAX) in combination with lenalidomide could deepen the clinical response in patients with multiple myeloma in sustained n
Autor:
Enrico Orciuolo, Susanna Grassi, Federico Rossari, Edoardo Benedetti, Cristina Zucchinetti, Elena Ciabatti, Eugenio Ciancia, Gabriele Buda, Ugo Boggi, Mario Petrini, Francesca Guerrini, Luca Biavati, Maria Immacolata Ferreri, Sara Galimberti, Francesco Caracciolo
We report the case of an aggressive non-Hodgkin lymphoma transmission from a live renal donor to her recipient. Soon after donation, the donor developed a high-grade B cell lymphoma, and the disease became evident also in the recipient three months t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ff9ca282230e5280fa0588c8cade307
https://doi.org/10.31487/j.cor.2019.02.02
https://doi.org/10.31487/j.cor.2019.02.02
Autor:
Carol Ann Huff, Lakshmi Rudraraju, Luca Biavati, Sarah K. Johnson, Ivan Borrello, Rachel M. Gittelman, Cristina Zucchinetti, Abbas Abbas Ali, Kimberly A. Noonan, Anna Ferguson, Catherine Sanders
Publikováno v:
Blood. 136:8-8
Introduction: Novel therapies have increased the complete response (CR) rates in multiple myeloma (MM) with corresponding improvement in progression free survival (PFS). However, relapse occurs in a significant number of patients. Emerging evidence s